Psoriatic Arthritis D2P Screening

Launched by JESSICA WALSH · Sep 27, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on improving the early detection of Psoriatic Arthritis (PsA) in patients who have psoriasis. The researchers want to develop a new way to screen for PsA that allows patients to fill out questionnaires on their own, without needing to visit a doctor’s office. This approach aims to reach more patients, especially those who may not regularly see a dermatologist, and help educate them about their risk of developing PsA, which could lead to earlier diagnosis and treatment.

To participate in the study, individuals must be 18 years or older and have been diagnosed with psoriasis but not yet diagnosed with PsA. Participants should live near the study location to make it easier to take part. Those who already have a confirmed diagnosis of PsA by a rheumatologist are not eligible. If you join the study, you can expect to complete questionnaires that will help the researchers gather important information about your condition. This study is currently recruiting participants, and your involvement could contribute to better ways of identifying PsA in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have an International Classification of Diseases (ICD) code diagnosis of psoriasis but without a confirmed diagnosis of Psoriatic Arthritis prior to study initiation
• • Be age 18 or older
• • Be geographically located within a reasonable proximity to the Rheumatology study site
• Exclusion Criteria:
• • Have psoriasis and a confirmed diagnosis of psoriatic arthritis made or confirmed by a rheumatologist